Skip to content

Comparison of Feasibility Between Internal and External Pancreatic Drainage in Pancreaticoduodenectomy

Comparison of Feasibility Between Internal and External Pancreatic Drainage in Pancreaticoduodenectomy: Prospective Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01023594
Enrollment
328
Registered
2009-12-02
Start date
2010-01-31
Completion date
2016-01-31
Last updated
2015-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Fistula

Keywords

Pancreatic fistula, Pancreatic leakage, Pancreatoduodenectomy, Pancreatic stent

Brief summary

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend pancreatic stent in pancreatojejunostomy. There are two distinct methods of pancreatic stent insertion: internal stent and external stent. There was few studies comparing these methods in preventing pancreatic fistula. Furthermore, its long-term effect was not known enough. The purpose of this study is to determine which is the best method in preventing pancreatic fistula and to investigate its long term clinical outcomes.

Interventions

Feeding tube insert at pancreatojejunostomy site as a stent. And then 1) tube is brought out through jejunal loop below the hepaticojejunostomy site and abdominal wall(external stent)or 2) tube is cut short (5cm length) and left in situ with fixating suture. In external stent group, tube will be removed about 1 months after operation.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* patient who have malignant or benign disease which needs pancreatoduodenectomy * patient age: ≥20 and ≤85

Exclusion criteria

* patient who had chemotherapy or radiotherapy previous to operation. * patient who had severe comorbid disease(cardiac, pulmonary, cerebrovascular) * patient who had past medical history of chronic pancreatitis. * pancreatic stent size \<1mm or \>5mm

Design outcomes

Primary

MeasureTime frame
evidence of pancreatic fistula confirmed by serum and drain amylasewithin the first 7 days after surgery

Secondary

MeasureTime frame
pancreatic endocrine and exocrine function by blood test, stool exam (steatorrhea) and computed tomography (CT) volumetrywithin the first 1 year after surgery

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026